Počet záznamů: 1
Preclinical Evaluation of (177)Lu-Nimotuzumab: A Potential Tool for Radioimmunotherapy of Epidermal Growth Factor Receptor-Overexpressing Tumors
- 1.BECKFORD, D. R., EIGNER, S., BERAN, M., EIGNER-HENKE, K., LÁZNÍČEK, M., MELICHAR, F., CHINOL, M. Preclinical Evaluation of (177)Lu-Nimotuzumab: A Potential Tool for Radioimmunotherapy of Epidermal Growth Factor Receptor-Overexpressing Tumors. Cancer Biotherapy and Radiopharmaceuticals. 2011, 26(3), 287-297. ISSN 1084-9785. E-ISSN 1557-8852. Dostupné z: doi: 10.1089/cbr.2010.0916
Počet záznamů: 1